Evaluating patients at-risk for antinuclear antibodies-associated systemic autoimmune rheumatic disease particularly systemic lupus erythematosus, Sjogren syndrome, and mixed connective tissue disease . Evaluating patients with signs and symptoms of a connective tissue disease in whom the test for antinuclear antibodies is positive